Jincaopian tablets for ongoing pelvic pain after pelvic infection
Part of Pain, Women’s health & pregnancy clinical trials.
This trial tests whether Jincaopian tablets can reduce long-lasting pelvic pain that happened after pelvic inflammatory disease. You may be able to join if your pain is still moderate to severe and other causes of pelvic pain have been ruled out.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of chronic pelvic pain caused by the aftermath of pelvic inflammatory disease
- Your average pelvic pain is at least 4 out of 10 over the week before enrollment
- Your physical signs score (McCormack scale) is between 4 and 12 at enrollment
- You are a woman aged 18 to 50 and have had sexual intercourse in your past history
- You can sign informed consent and agree to take part voluntarily
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether psilocybin (a psychedelic drug) can help women with long-term pelvic pain that hasn't gotten better with standard treatments. The goal is to see if it's possible and safe to use this approach in a future larger study.
This study tests a conservative (non-surgical, non-medication) approach to help women service members with long-lasting pelvic or lower belly pain. It aims to see if this care can reduce pain and improve daily life.
This trial tests if a non-invasive brain stimulation device can reduce pelvic pain. You will be randomly assigned to one of three groups: stimulation over the spine, over a nerve bundle, or a placebo (sham) treatment. The study aims to find a new treatment option for people whose pain has not responded to standard therapies.
This trial tests a skin patch treatment (acupoint application) placed on specific points of the body to help relieve ongoing pelvic pain from pelvic inflammatory disease. It may be a good option if you have moderate pain and ultrasound findings of tubal thickening or fluid.
This trial tests a new drug called GenSci048 to see if it can reduce moderate to severe pain caused by endometriosis. It might be an option if you have regular periods and are willing to switch to only the pain relievers allowed in the study.
This trial tests if a non-invasive nerve stimulation device (TaVNS) can reduce pain, urinary symptoms, and mood issues in men with moderate to severe chronic pelvic pain syndrome (CP/CPPS). It may offer a new drug-free option for symptom relief.
Hear when a new Chronic Pelvic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.